Mesa Laboratories, Inc.
General ticker "MLAB" information:
- Sector: Information Technology
- Industry: Hardware, Equipment & Parts
- Capitalization: $483.4M (TTM average)
Mesa Laboratories, Inc. follows the US Stock Market performance with the rate: 57.7%.
Estimated limits based on current volatility of 1.7%: low 124.14$, high 128.44$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-08-31, amount 0.16$ (Y0.52%)
- Total employees count: 717 (-1.8%) as of 2026
- China accounted for 10.5% of revenue in the fiscal year ended 2025-03-31
- US accounted for 48.4% of revenue in the fiscal year ended 2025-03-31
- Top business risk factors: Geopolitical risks, Market volatility, Supply chain disruptions, Regulatory and compliance, Cybersecurity threats
- Current price 14.5% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-03-31 to 2028-03-30
- 2026-03-31 to 2027-03-31 estimated range: [70.72$, 107.01$]
- 2027-03-31 to 2028-03-30 estimated range: [69.78$, 106.92$]
Financial Metrics affecting the MLAB estimates:
- Positive: with PPE of 8.4 at the end of fiscal year the price was neutral
- Positive: 4.60 < Operating profit margin, % of 7.43
- Positive: -1.23 < Investing cash flow per share per price, % of -0.71
- Positive: -4.55 < Industry operating profit margin (median), % of 0.01
- Positive: 8.77 < Operating cash flow per share per price, % of 9.35
- Positive: 0.90 < Industry operating cash flow per share per price (median), % of 2.14
Short-term MLAB quotes
Long-term MLAB plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating Revenue | $216.19MM | $240.98MM | $249.13MM |
| Operating Expenses | $488.26MM | $224.64MM | $230.62MM |
| Operating Income | $-272.07MM | $16.34MM | $18.51MM |
| Non-Operating Income | $-3.57MM | $-10.38MM | $-6.50MM |
| Interest Expense | $5.70MM | $11.86MM | $10.69MM |
| R&D Expense | $19.30MM | $19.52MM | $20.31MM |
| Income(Loss) | $-275.65MM | $5.96MM | $12.01MM |
| Taxes | $-21.40MM | $7.93MM | $5.30MM |
| Net Income(Loss)* | $-254.25MM | $-1.97MM | $6.71MM |
| Stockholders Equity | $145.39MM | $159.83MM | $186.25MM |
| Inventory | $32.67MM | $25.36MM | $26.37MM |
| Assets | $446.80MM | $433.35MM | $427.75MM |
| Operating Cash Flow | $44.13MM | $46.81MM | $42.83MM |
| Capital expenditure | $2.57MM | $4.50MM | $3.25MM |
| Investing Cash Flow | $-81.31MM | $-4.50MM | $-3.25MM |
| Financing Cash Flow | $32.84MM | $-44.51MM | $-41.85MM |
| Earnings Per Share** | $-47.20 | $-0.36 | $1.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.